2 news items
Spyre Therapeutics Appoints Accomplished Biopharma Leader Dr. Sandra Milligan to its Board of Directors
SYRE
15 May 24
Women's Health, to its Board of Directors.
"With a distinguished career spanning leadership roles
Spyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
SYRE
9 May 24
of corporate leadership, product development, and value creation will be instrumental to guide the Company as it advances its potentially best-in-class IBD
- Prev
- 1
- Next